Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 17, 2015 11:38 PM ET

Biotechnology

Company Overview of Idenix Pharmaceuticals Inc.

Executive Profile

Daniella Beckman

Chief Financial Officer, Principal Accounting Officer, Senior Vice President and Treasurer, Idenix Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 1 different industries.

35$741,272
As of Fiscal Year 2013

Background

Ms. Daniella Beckman has been the Chief Financial Officer and Treasurer at Idenix Pharmaceuticals Inc., since June 2, 2011 and also serves as its Principal Accounting Officer. Ms. Beckman has been Senior Vice President of Idenix Pharmaceuticals Inc., since June 2012. Ms. Beckman served as Vice President at Idenix Pharmaceuticals Inc., from June 2, 2011 June 2012. She served as Interim Chief Financial Officer and Interim Treasurer of Idenix Pharmaceuticals from October ...

Corporate Headquarters

320 Bent Street
Cambridge, Massachusetts 02141

United States

Phone: 617-995-9800
Fax: 617-995-9801

Board Members Memberships

There is no Board Members Memberships data available.

Education

BA
Boston University

Other Affiliations

Annual Compensation

Salary$328,269
Total Annual Compensation$328,269

Stocks Options

All Other Compensation$8,773
Exercisable Options$153,345
Exercisable Options Value$172,679
Unexercisable Options$155,155
Unexercisable Options Value$150,791
Total Value of Options$323,470
Total Number of Options$308,500

Total Compensation

Total Annual Cash Compensation$438,042
Total Short Term Compensation$328,269
Other Long Term Compensation$8,773
Total Calculated Compensation$741,272
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Idenix Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.